These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 19671593)

  • 1. Outcomes predicted by phosphorous in chronic kidney disease: a retrospective CKD-inception cohort study.
    Smith DH; Johnson ES; Thorp ML; Petrik A; Yang X; Blough DK
    Nephrol Dial Transplant; 2010 Jan; 25(1):166-74. PubMed ID: 19671593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variability and risk factors for kidney disease progression and death following attainment of stage 4 CKD in a referred cohort.
    Levin A; Djurdjev O; Beaulieu M; Er L
    Am J Kidney Dis; 2008 Oct; 52(4):661-71. PubMed ID: 18805347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting the risk of dialysis and transplant among patients with CKD: a retrospective cohort study.
    Johnson ES; Thorp ML; Platt RW; Smith DH
    Am J Kidney Dis; 2008 Oct; 52(4):653-60. PubMed ID: 18585833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The importance of serum albumin and phosphorous as predictors of mortality in ESRD patients.
    Phelan PJ; O'Kelly P; Walshe JJ; Conlon PJ
    Ren Fail; 2008; 30(4):423-9. PubMed ID: 18569917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of anaemia on mortality, cardiovascular hospitalizations and end-stage renal disease among patients with chronic kidney disease.
    Thorp ML; Johnson ES; Yang X; Petrik AF; Platt R; Smith DH
    Nephrology (Carlton); 2009 Apr; 14(2):240-6. PubMed ID: 19207866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting renal replacement therapy and mortality in CKD.
    Johnson ES; Thorp ML; Yang X; Charansonney OL; Smith DH
    Am J Kidney Dis; 2007 Oct; 50(4):559-65. PubMed ID: 17900455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of phosphorus and calcium-phosphorus product with mortality in CKD.
    Menon V; Greene T; Pereira AA; Wang X; Beck GJ; Kusek JW; Collins AJ; Levey AS; Sarnak MJ
    Am J Kidney Dis; 2005 Sep; 46(3):455-63. PubMed ID: 16129207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ERA-EDTA cohort study--comparison of methods to predict survival on renal replacement therapy.
    Geddes CC; van Dijk PC; McArthur S; Metcalfe W; Jager KJ; Zwinderman AH; Mooney M; Fox JG; Simpson K
    Nephrol Dial Transplant; 2006 Apr; 21(4):945-56. PubMed ID: 16339161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haemoglobin at time of referral prior to dialysis predicts survival: an association of haemoglobin with long-term outcomes.
    Levin A; Djurdjev O; Duncan J; Rosenbaum D; Werb R
    Nephrol Dial Transplant; 2006 Feb; 21(2):370-7. PubMed ID: 16249203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum phosphate levels and mortality risk among people with chronic kidney disease.
    Kestenbaum B; Sampson JN; Rudser KD; Patterson DJ; Seliger SL; Young B; Sherrard DJ; Andress DL
    J Am Soc Nephrol; 2005 Feb; 16(2):520-8. PubMed ID: 15615819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Predictors of early death during dialysis].
    Caravaca F; Arrobas M; Pizarro JL; Cancho B; Cubero JJ; Espárrago JF; García MC; Sánchez-Casado E
    Nefrologia; 2001; 21(3):274-82. PubMed ID: 11471308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting mortality and uptake of renal replacement therapy in patients with stage 4 chronic kidney disease.
    Conway B; Webster A; Ramsay G; Morgan N; Neary J; Whitworth C; Harty J
    Nephrol Dial Transplant; 2009 Jun; 24(6):1930-7. PubMed ID: 19181760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploratory study of relationship between hospitalized heart failure patients and chronic renal replacement therapy.
    Liang KV; Greene EL; Williams AW; Herzog CA; Hodge DO; Owan TE; Redfield MM
    Nephrol Dial Transplant; 2009 Aug; 24(8):2518-23. PubMed ID: 19176683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The natural history of chronic renal failure: results from an unselected, population-based, inception cohort in Sweden.
    Evans M; Fryzek JP; Elinder CG; Cohen SS; McLaughlin JK; Nyrén O; Fored CM
    Am J Kidney Dis; 2005 Nov; 46(5):863-70. PubMed ID: 16253726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementing KDOQI CKD definition and staging guidelines in Southern California Kaiser Permanente.
    Rutkowski M; Mann W; Derose S; Selevan D; Pascual N; Diesto J; Crooks P
    Am J Kidney Dis; 2009 Mar; 53(3 Suppl 3):S86-99. PubMed ID: 19231766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study.
    Go AS; Yang J; Ackerson LM; Lepper K; Robbins S; Massie BM; Shlipak MG
    Circulation; 2006 Jun; 113(23):2713-23. PubMed ID: 16754803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased risk of mortality in the elderly population with late-stage chronic kidney disease: a cohort study in Taiwan.
    Hwang SJ; Lin MY; Chen HC; Hwang SC; Yang WC; Hsu CC; Chiu HC; Mau LW
    Nephrol Dial Transplant; 2008 Oct; 23(10):3192-8. PubMed ID: 18450830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic kidney disease in long-term survivors of myeloablative allogeneic haematopoietic cell transplantation: prevalence and risk factors.
    Ando M; Ohashi K; Akiyama H; Sakamaki H; Morito T; Tsuchiya K; Nitta K
    Nephrol Dial Transplant; 2010 Jan; 25(1):278-82. PubMed ID: 19762604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated serum levels of S-adenosylhomocysteine, but not homocysteine, are associated with cardiovascular disease in stage 5 chronic kidney disease patients.
    Valli A; Carrero JJ; Qureshi AR; Garibotto G; Bárány P; Axelsson J; Lindholm B; Stenvinkel P; Anderstam B; Suliman ME
    Clin Chim Acta; 2008 Sep; 395(1-2):106-10. PubMed ID: 18565329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperhomocysteinemia in relation to plasma free amino acids, biomarkers of inflammation and mortality in patients with chronic kidney disease starting dialysis therapy.
    Suliman ME; Stenvinkel P; Qureshi AR; Bárány P; Heimburger O; Anderstam B; Alvestrand A; Lindholm B
    Am J Kidney Dis; 2004 Sep; 44(3):455-65. PubMed ID: 15332218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.